Becton, Dickinson and Company BDX, popularly known as BD, recently unveiled the BD FACSDiscover A8 Cell Analyzer. This advanced platform integrates breakthrough spectral flow cytometry with real-time ...
Featured in the journal Science and unveiled at last year’s International Society for Advancement of Cytometry CYTO conference, BD‘s first-of-its-kind cell-sorting technology has now launched ...
BD Prevue™ II System Equips Clinicians with Connected Ultrasound Technology to Drive More Intuitive IV Placement and Control FRANKLIN LAKES, N.J., April 11, 2023 /PRNewswire/ -- BD (Becton, Dickinson ...
BD’s new MiniDraw diagnostic devices could let pharmacists—and, one day, maybe patients—manage blood testing needs and monitor health conditions. BD received its FDA authorizations for two blood draw ...
FRANKLIN LAKES, N.J., July 23, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announces the first pharma-sponsored combination ...
BD Launches New Cell Analyzer Configurations to Bring Cutting-Edge Capabilities to Labs of All Sizes
FRANKLIN LAKES, N.J., Dec. 3, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the global commercial release of new ...
Combination unlocks new future value-creation opportunities and is expected to be immediately accretive to BD revenue growth, adjusted gross margin, adjusted operating margin and adjusted EPS Expands ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results